No Detail Found!

Clinical significances of circulating serum fetuin-A, netrin-1, and ɑ-hydroxybutyrate levels in type 2 diabetes mellitus patients with and without hypertension

Author(s)
Hussein Saeed Sfayyih College of Health and Medical Techniques/Al-Basrah, Southern Technical University, Ministry of Higher Education and Scientific Research,,Iraq
Abdulkareem M. Jewad College of Health and Medical Techniques/Al-Basrah, Southern Technical University, Ministry of Higher Education and Scientific Research,,Iraq
Hasan Abd Ali Khudhair Al-Nasiriyah Technical Institute, Southern Technical University, Ministry of Higher Education and Scientific Research,,Iraq
Abstract
Background & Objective: Type 2 diabetes (T2D) is a rising global health issue, with biomarkers such as fetuin-A (FetA), netrin-1 (NTN-1), and alpha-hydroxybutyrate (a-HB) showing potential for early diagnosis and management. These biomarkers can help predict T2D risk and understand insulin resistance (IR), emphasizing the need for further research. The current investigation evaluated the effectiveness of Fet-A, NTN-1, and, a-HB as novel biomarkers to diagnose T2D with hypertension. Methodology: A cross-sectional study was conducted from August to December 2023, involved 60 diabetic participants, which were divided into two groups: T2D without hypertension and T2D with hypertension. A third group consisted of 30 healthy controls (HC) for comparison. Serum samples were analyzed for fasting blood glucose (FBG) using the Roche/Cobas c111 system, as well as insulin, Fet-A, NTN-1, and a-HB levels using kits for the enzymelinked immune-sorbent assay (ELISA). Descriptive statistics were used in the statistical package for social sciences (SPSS) for data analysis. Results: The study found significantly elevated Fet-A, NTN-1, and a-HB levels in T2D patients compared to HC, with no significant differences between T2D subgroups. Fetuin-A and a-HB showed non-significant correlations with FBG and homeostatic model assessment of IR (HOMA-IR) across all groups. NTN-1 positively correlated with FBG and HOMA-IR in T2D patients with hypertension. Conclusions: Elevated levels of fetuin-A and netrin-1, regardless of the presence of hypertension, are suggested by the study as possible biomarkers for the diagnosis of T2D. Netrin-1's significant correlation with HOMA-IR in hypertensive T2D patients underscores its utility in assessing insulin resistance severity. Although alphahydroxybutyrate levels were higher in T2D patients, their non-significant correlation with FBG and HOMA-IR requires further research. These biomarkers could aid in early diagnosis and disease monitoring for T2D management. Abbreviations: a-KB - a-ketobutyrate; ELISA - enzyme linked immune-sorbent assay; FA - fatty acids; FBG - fasting blood glucose; Fet-A - fetuin-A; HOMA-IR - homeostatic model assessment of IR; IR - insulin resistance; NAD nicotinamide adenine dinucleotide; NADH - nicotinamide adenine dinucleotide hydrogen; ng - nanograms; NTN-1 netrin-1; PB - peripheral blood; pg - picogram; SPSS - Statistical Package for Social Sciences; T2D - Type-2 diabetes mellitus; a-HB - alpha-hydroxybutyrate
Publication Details
Page(s) 883-893
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 28, Issue: 5, Year: 2024

Request the full text from PASTIC

Keywords
fetuin-A, Diabetes, Diabetes, HOMA-IR, Netrin-1, a-HB
References
Perreault L,Skyler JS,Rosenstock J .2021 .Novel therapies with precision mechanisms for type 2 diabetes mellitus. Nat Rev Endocrinol, 17(6) : 364-77.
Halim M,Halim A .2019 .The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metab Syndr, 01(2) : 1165-72.
Magliano DJ,Boyko EJ .2021 .IDF Diabetes Atlas 10th edition scientific committee. IDF Diabetes Atlas. 10th ed. Int Diabetes Fed, : .
Goyal R,Singhal M,Jialal I,Castano M. .2023 .Type 2 Diabetes (Nursing). , : .
Caturano A,D'Angelo M,Mormone A,Russo V,Mollica MP,Salvatore T .2023 .Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications. Curr Issues Mol Biol, 45(8) : 6651-66.
Przezak A,Bielka W,Pawlik A .2022 .Hypertension and type 2 diabetes-the novel treatment possibilities. Int J Mol Sci, 23(12) : 6500.
Ward K,Mulder E,Frings-Meuthen P,O'Gorman DJ,Cooper D .2020 .Fetuin-A as a potential biomarker of metabolic variability following 60 days of bed rest. Front Physiol, 11 : 573581.
Bourebaba L,Marycz K. .2033 .Pathophysiological implication of fetuinA glycoprotein in the development of metabolic disorders: a concise review. J Clin Med, 8(12) : .
Sardana O,Goyal R,Bedi O .2021 .Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD. , 29(4) : 1061-74.
Stefan N,Fritsche A,Weikert C,Boeing H,Joost HG,Häring HU .2008 .Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes, 57(10) : 0538-7.
Fadel MM,Ghaffar FR,Zwain SK,Ibrahim HM .2021 .Serum netrin and VCAM-1 as biomarker for Egyptian patients with type IΙ diabetes mellitus. Biochem Biophys Rep, 27 : 101045.
Ziegon L,Schlegel M .2021 .Netrin-1: A modulator of macrophage driven acute and chronic inflammation. Int J Mol Sci, 23(1) : 275.
Nedeva I,Gateva A,Assyov Y,Karamfilova V,Velikova T .2020 .Relationship between circulating netrin-1 levels, obesity, prediabetes and newly diagnosed type 2 diabetes. Arch Physiol Biochem, 128(6) : 1533-8.
DeFronzo RA,Tripathy D. .2009 .Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care, 32(Suppl 2) : .
Suvitaival T,Mantere O,Kieseppä T,Mattila I,Pöhö P,Hyötyläinen T .2016 .Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis. Transl Psychiatry, 6(11) : e951.
Puchalska P,Crawford PA. .2016 .Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab, 12(2) : 262-84.
Mahendran Y,Jonsson A,Have CT,Allin KH,Witte DR,Jørgensen ME .2017 .Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels. Diabetologia, 60(5) : 873-8.
Lin JD,Chen YL,Wu CZ,Hsieh CH,Pei D,Liang YJ .2016 .Identification of normal blood pressure in different age groups. Medicine, 95(14) : .
Majid H,Masood Q,Khan AH .2017 .Homeostatic model assessment for insulin resistance (HOMA-IR): a better marker for evaluating insulin resistance than fasting insulin in women with polycystic ovarian syndrome. J Coll Physicians Surg Pak, 27(3) : 123-6.
Lanthier N,Lebrun V,Molendi-Coste O,van Rooijen N,Leclercq IA .2022 .Liver fetuin-A at initiation of insulin resistance. Metabolites, 12(11) : 1023.
Afrisham R,Hashemnia SM,Majidi Z,Mozaffari S,Vahidi M. .2020 .Association of fetuin-A with the pathogenesis of metabolic diseases. Int J Biomed Public Health, 3(3) : 95-102.
Brix JM,Stingl H,Höllerl F,Schernthaner GH,Kopp HP,Schernthaner G .2010 .Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab, 95(11) : 0148-81.
Guo VY,Cao B,Cai C,Cheng KK,Cheung BMY .2018 .Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Acta Diabetol, 55 : 87-98.
Sujana C,Huth C,Zierer A,Meesters S,Sudduth-Klinger J,Koenig W .2018 .Association of fetuin-A with incident type 2 diabetes: results from the MONICA/KORA Augsburg study and a systematic meta-analysis. Eur J Endocrinol, 178(4) : 389-98.
Goustin AS,Derar N,Abou-Samra AB .2012 .Ahsg-fetuin blocks the metabolic arm of insulin action through its interaction with the 95-kD β-subunit of the insulin receptor. Cell Signal, 12(4) : 981-8.
Xia X,Hu Z,Wang S,Yin K. .2022 .Netrin-1: An emerging player in inflammatory diseases. Cytokine Growth Factor Rev, 01 : 46-56.
Shalaby A,El Mancy IM .2021 .Study of serum Netrin-1 level in prediabetics and type 2 diabetic Egyptian patients. Al-Azhar Int Med, 2(6) : 17-22.
Yimer EM,Zewdie KA,Hishe HZ,Diabetes‐Associated Complications HZ .2018 .Netrin as a Novel Biomarker and Its Therapeutic Implications in Diabetes Mellitus. J Diabetes Res, : 8250521.
Natura G,Bär KJ,Eitner A,Boettger MK,Richter F,Hensellek S .2013 .Neuronal prostaglandin E2 receptor subtype EP3 mediates antinociception during inflammation. Proc Natl Acad Sci, 110(33) : 13648-53.
Ramkhelawon B,Hennessy EJ,Ménager M,Ray TD,Sheedy FJ,Hutchison S . .Netrin-1 promotes adipose tissue. , : .
Ferrannini E,Natali A,Camastra S,Nannipieri M,Mari A,Adam KP .2013 .Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes, 62(5) : 0707-7.
Menni C,Fauman E,Erte I,Perry JR,Kastenmüller G,Shin SY .2013 .Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes, 62(12) : 0570-6.
Padberg I,Peter E,González-Maldonado S,Witt H,Mueller M,Weis T .2014 .A new metabolomic signature in type-2 diabetes mellitus and its pathophysiology. PLoS One, 9(1) : .
Dudzik D,Zorawski M,Skotnicki M,Zarzycki W,García A,Angulo S .2017 .GC-MS based Gestational Diabetes Mellitus longitudinal study: Identification of 2-and 3-hydroxybutyrate as potential prognostic biomarkers. J Pharm Biomed Anal, 02 : 90-8.
Varvel SA,Pottala JV,Thiselton DL,Caffrey R,Dall T,Sasinowski M .2014 .Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT. -000038, 2(1) : .
Karpe F,Dickmann JR,Frayn KN .2011 .Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes, 60(10) : 0425-9.
Cobb J,Gall W,Adam KP,Nakhle P,Button E,Hathorn J .2013 .A novel fasting blood test for insulin resistance and prediabetes. J Diabetes Sci Technol, 7(1) : 100-10.
Sarı H,Esen B,Yıldırım S,Pilten S,Aydın H.,Serum H. .2016 .- hydroxybutyrate: a candidate marker of insulin resistance is associated with deterioration in anthropometric measurements in individuals with low diabetes risk. J Appl Lab Med, 1(5) : 562-7.
Tseng Z,White Y,MF Y .2010 .Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab, 06(10) : 589-98.
Ix JH,Shlipak MG,Brandenburg VM,Ali S,Ketteler M,Whooley MA .2006 .Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation, 113(14) : 1760-7.
Stefan N,Hennige AM,Staiger H,Machann J,Schick F,Kröber SM .2006 .-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care, 29(4) : 1938-7.
Reinehr T,Roth CL .2008 .Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab, 93(11) : 1505-85.
Al-Shakour AA,Khalid HK,Mahmood I,Al-Sudani MY,Majeed M. .2024 .Serum netrin-1 level in patients with type 2 diabetes mellitus and its relationship with diabetic complications. Anaesth Pain Intensive Care, 28(2) : 347-52.
Jebar RS,Saleh BO,Almaliky AA .2023 .Alpha hydroxyl butyrate as a marker for prediction of familial type 2 diabetes mellitus in Iraqi apparently healthy. Acta Biomed, 94(2) : .
Gall WE,Beebe K,Lawton KA,Adam KP,Mitchell MW,Nakhle PJ .2010 .α-Hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One, 5(5) : .
Lotta LA,Scott RA,Sharp SJ,Burgess S,Luan JA,Tillin T .2016 .Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: a Mendelian randomisation analysis. PLoS Med, 13(11) : .
0

Citations

0

Downloads

60

Views